Endoscopic Screening and Surveillance: Indications and Standards

  • Frieder BerrEmail author
  • Thierry Ponchon
  • Tsuneo Oyama


Endoscopy is the gold standard for detection of early cancer in the gastrointestinal tract. For normal-risk asymptomatic persons, endoscopic screening of the upper and lower gastrointestinal tract is recommended in Japan starting at the age of 40 years. In many Western countries, colonoscopy only is approved for cancer screening starting at the age of 50 years. As rationale serves that colonoscopic screening with resection of all neoplastic lesions had strongly reduced the incidence of colorectal cancer during subsequent follow-up for 10 years. High-risk groups are subject to different, more frequent endoscopic surveillance programs which we summarize for esophageal, gastric, and colorectal cancer. We explain the preparation and procedural steps of screening colonoscopy and esophago-/gastroscopy including benchmark criteria for quality of endoscopic screening.


Gastric Cancer Familial Adenomatous Polyposis Early Gastric Cancer Intestinal Metaplasia Surveillance Endoscopy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors gratefully acknowledge Toshio Uroaka MD for critical discussion and improvements in the manuscript of this chapter.


  1. 1.
    GLOBOCAN database, International Agency for Research on Cancer, WHO.
  2. 2.
    Boyle P, et al. World cancer report 2008. WHO Press; 2008.Google Scholar
  3. 3.
    Everett SM, et al. Early gastric cancer in Europe. Gut. 1997;41:142–50.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Morita S, et al. Outcome of pylorus-preserving gastrectomy for early gastric cancer. Br J Surg. 2008;95:1131–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Abe S, et al. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy. 2013;45:703–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Gotoda T, et al. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–71.PubMedCrossRefGoogle Scholar
  7. 7.
    Saito H. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum. 2000;43:S78–84.PubMedCrossRefGoogle Scholar
  8. 8.
    Levin B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95.PubMedCrossRefGoogle Scholar
  9. 9.
    Watanabe T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17:1–29.PubMedCrossRefGoogle Scholar
  10. 10.
    Pox C, et al. S3-guideline colorectal cancer version 1.0. Z Gastroenterol. 2013;51:753–854.PubMedCrossRefGoogle Scholar
  11. 11.
    Fletcher RH, et al. Screening patients with a family history of colorectal cancer. J Gen Intern Med. 2007;22:508–13.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Hirota WK, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570–80.PubMedCrossRefGoogle Scholar
  13. 13.
    Vasen HF, et al. Familial colorectal cancer risk: ESMO clinical recommendations. Ann Oncol. 2009;20 Suppl 4:51–3.PubMedGoogle Scholar
  14. 14.
    Zauber AG, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–96.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Center MM, et al. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18:1688–94.PubMedCrossRefGoogle Scholar
  16. 16.
    Jemal A, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.PubMedCrossRefGoogle Scholar
  17. 17.
    Hamashima C, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008;38:259–67.PubMedCrossRefGoogle Scholar
  18. 18.
    Leung WK, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–87.PubMedCrossRefGoogle Scholar
  19. 19.
    Watabe H, et al. Predicting the development of gastric cancer from combining helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Lau M, et al. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006;101:2485–92.PubMedCrossRefGoogle Scholar
  21. 21.
    Towler B, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ. 1998;317:559–65.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Sieg A, et al. Results of coloscopy screening in 200--n Internet-based documentation. Dtsch Med Wochenschr. 2006;131:379–83.Google Scholar
  23. 23.
    Winawer SJ, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594–642.PubMedCrossRefGoogle Scholar
  24. 24.
    Winawer S, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544–60.PubMedCrossRefGoogle Scholar
  25. 25.
    Johns LE, et al. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003.PubMedCrossRefGoogle Scholar
  26. 26.
    Dunlop MG. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut. 2002;51 Suppl 5:V21–7.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Giardiello FM, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447–53.PubMedCrossRefGoogle Scholar
  28. 28.
    Farraye FA, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746–74. 774 e741-744; quiz e712-743.PubMedCrossRefGoogle Scholar
  29. 29.
    Rutter MD, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Dove-Edwin I, et al. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ. 2005;331:1047.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Itzkowitz SH, et al. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–21.PubMedCrossRefGoogle Scholar
  32. 32.
    Lee KJ, et al. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer. 2006;118:2315–21.PubMedCrossRefGoogle Scholar
  33. 33.
    Huntsman DG, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001;344:1904–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Engel LS, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–13.PubMedCrossRefGoogle Scholar
  35. 35.
    Kuwano H, et al. Guidelines for diagnosis and treatment of neoplasias of the esophagus. April 2007 edition: part I. Edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.CrossRefGoogle Scholar
  36. 36.
    Ribeiro Jr U, et al. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996;83:1174–85.PubMedCrossRefGoogle Scholar
  37. 37.
    Erkal HS, et al. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol. 2001;19:1358–62.PubMedGoogle Scholar
  38. 38.
    Ina H, et al. The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer. Screening results using Lugol dye endoscopy. Cancer. 1994;73:2038–41.PubMedCrossRefGoogle Scholar
  39. 39.
    Appelqvist P, et al. Lye corrosion carcinoma of the esophagus: a review of 63 cases. Cancer. 1980;45:2655–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Sandler RS, et al. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA. 1995;274:1359–62.PubMedCrossRefGoogle Scholar
  41. 41.
    Stevens HP, et al. Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol. 1996;132:640–51.PubMedCrossRefGoogle Scholar
  42. 42.
    Abnet CC, et al. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst. 2005;97:301–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Mark SD, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst. 2000;92:1753–63.PubMedCrossRefGoogle Scholar
  44. 44.
    Shuyama K, et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer. 2007;96:1554–9.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Spechler SJ, et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91.PubMedCrossRefGoogle Scholar
  46. 46.
    Oettle GJ, et al. Esophagitis in a population at risk for esophageal carcinoma. Cancer. 1986;57:2222–9.PubMedCrossRefGoogle Scholar
  47. 47.
    El-Serag HB, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50:368–72.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Buttar NS, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Lagergren J, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.PubMedCrossRefGoogle Scholar
  50. 50.
    Gray MR, et al. The role of smoking and alcohol in metaplasia and cancer risk in Barrett’s columnar lined oesophagus. Gut. 1993;34:727–31.PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    Faigel DO, et al. Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol. 2006;101:866–72.PubMedCrossRefGoogle Scholar
  52. 52.
    Kudo S, et al. The problem of de novo colorectal carcinoma. Eur J Cancer. 1995;31A:1118–20.PubMedCrossRefGoogle Scholar
  53. 53.
    Okawa K, et al. Colonoscopy. In: Arakawa T editor. Learning skills for gastrointestinal endoscopy. Basic knowledge and strategies: lessons from Japan. Tokyo: The Asahi Shimbun Company; 2006. p. 96–117.Google Scholar
  54. 54.
    Oyama T. Endoscopic diagnosis of gastric adenocarcinoma for ESD. Tokyo: Nankodo Co., Ltd.; 2010.Google Scholar
  55. 55.
    Oyama T. Diagnostic strategies of superficial Barrett’s esophageal cancer for endoscopic submucosal dissection. Dig Endosc. 2013;25 Suppl 1:7–12.PubMedCrossRefGoogle Scholar
  56. 56.
    Uchido T, et al. Esophagogastroduodenoscopy. In: Arakawa T editor. Learning skills for gastrointestinal endoscopy. Basic knowledge and strategies: lessons from Japan. Tokyo: The Asahi Shimbun Company; 2006. p. 18–40.Google Scholar
  57. 57.
    Anderson MA, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009;70:1060–70.PubMedCrossRefGoogle Scholar
  58. 58.
    Banerjee S, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67:791–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Internal Medicine IParacelsus Medical University/Salzburger LandesklinikenSalzburgAustria
  2. 2.Department of Digestive DiseasesHôpital Eduard Herriot, Pavillon H, Place d’ArsonvalLyonFrance
  3. 3.Department of EndoscopySaku Central Hospital Advanced Care CenterSakuJapan

Personalised recommendations